Req ID: 17060
Job Category: Global Medical Affairs
Location: Zurich, Zurich
Posting Date: December 11, 2019
ApplyAttention: If you are a current Alexion employee, please apply via Alexion’s internal Life & Career portal. Note that you will need to be connected to the VPN if you are applying away from the office.
Alexion does not contact candidates via instant messaging or chat tools. At no time will we ask candidates for fees associated with obtaining software, nor do we provide employees with a cashier’s check to purchase new equipment. If you are contacted in this manner, please be aware that it is fraudulent, and please do not provide any information or money to these individuals. Applicants should only apply through this Alexion website. Any fraudulent activity should be reported to GSOC@alexion.com
Position Summary
The Associate Director Medical Affairs Launch Excellence (ADMALE) provides support to the country medical teams for them to execute first class medical affairs activities for launch of new products in the relevant markets. Additionally, he/she assembles reports on the progress of medical affairs activities and on insights achieved through Medical Affairs activities.
The ADMALE will report directly to the Senior Medical Director Launch Excellence International/Japan.
Principal Responsibilities
Internal Readiness
In collaboration with the Global Medical Affairs Leads, Commercial Launch Lead & Country Medical Affairs
Medical Intelligence
Ensure that valuable feedback from the field to be shared with internal stakeholders (incl. competitive intelligence)
KOLs Engagement
Drive the identification of National and Supra-national (Regional) Key Opinion Leaders
Provide Countries with KPIs for Launch Readiness
Scientific Communication
Identify and address relevant educational gaps and relay those to Global and Country Medical Affairs
Medical Information
Ensure that countries’ medical information needs are met (e.g. through FAQs)
Compliance
Stay current of local laws and guidelines, codes of practices and Alexion policies relevant to Medical Affairs activity
Qualifications
Minimum 4 years of experience in the Pharmaceutical / Biotechnology industry either in a Medical, Clinical, or commercial role
Previous experience in rare diseases is a definite plus
Proven capacity to:
Positive attitude during challenging situations
Administrative and organizational skills essential
Education
Relevant scientific degree
Fluent in English, written and spoken
Competencies
Integrity and trust
Accountability
Customer focus
Plans and aligns
Collaboration
Communication and presentation skills
Zurich, Switzerland
Some opportunities happen only once in a lifetime – like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) as well as the first and only approved complement inhibitor to treat atypical hemolytic uremic syndrome (aHUS), anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition, the company is developing several mid-to-late-stage therapies, including a second complement inhibitor, a copper-binding agent for Wilson disease and an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases as well as several early-stage therapies, including one for light chain (AL) amyloidosis and a second anti-FcRn therapy. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders. Alexion has been named to the Forbes’ list of the World’s Most Innovative Companies seven years in a row and is headquartered in Boston, Massachusetts’ Innovation District. The company also has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.